New Zealand Allows Clinics To Dose Isotane For Acne
This article was originally published in PharmAsia News
Executive Summary
Skin-care treatment centers in New Zealand moved quickly to take advantage of a decision by the Pharmaceutical Management Agency of New Zealand to allow coverage of broader sales of Pacific Pharmaceuticals' Isotane (isotretinoin). The Skin Institute and others had anticipated PHARMAC's decision to expand the authority to write prescriptions for the anti-acne drug beyond physician offices. The institute, a national skincare chain, had pressed for approving acne clinics to prescribe the drugs, citing equity-of-access issues. (Click here for more
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.